Table 2.
Proposed measures for improving cancer care
| NM | FGM | SGM/TGM | p-value | |
|---|---|---|---|---|
| Shorter therapy | 65 (14.8%) | 22 (20.8%) | 11 (18.3%) | 0.29 |
| Better cooperation between physicians | 112 (25.5%) | 26 (24.5%) | 21 (35.0%) | 0.26 |
| More consultation time | 134 (30.5%) | 40 (37.7%) | 27 (45.0%) | 0.04 |
| Therapies without alopecia | 126 (28.6%) | 29 (27.4%) | 18 (30.0%) | 0.93 |
| More measures for pain prevention | 41 (9.3%) | 17 (16.0%) | 10 (16.7%) | 0.05 |
| More measures for fatigue prevention | 107 (24.3%) | 27 (25.5%) | 15 (25.0%) | 0.97 |
| More measures for nausea prevention | 24 (5.5%) | 6 (5.7%) | 9 (15.0%) | 0.02 |
| Better nursing care | 69 (15.7%) | 12 (11.3%) | 11 (18.3%) | 0.41 |
| Therapy progress should be reported to patients more often | 85 (19.3%) | 20 (18.9%) | 7 (11.7%) | 0.36 |
| More effective therapies | 122 (27.7%) | 34 (32.1%) | 11 (18.3%) | 0.16 |
| Doctor consultation with interpreter | 9 (2.0%) | 26 (24.5%) | 1 (1.7%) | < 0.05 |
| Intercultural training for medical staff | 47 (10.7%) | 24 (22.6%) | 11 (18.3%) | 0.003 |
| Information in different languages | 49 (11.1%) | 37 (34.9%) | 9 (15.0%) | < 0.05 |